Propofol vs etomidate for induction prior to invasive mechanical ventilation in patients with acute myocardial infarction
American Heart Journal(2024)
摘要
Background
Patients with acute myocardial infarction (AMI) requiring invasive mechanical ventilation (IMV) have a high mortality. However, little is known regarding the impact of induction agents, used prior to IMV, on clinical outcomes in this population. We assessed for the association between induction agent and mortality in patients with AMI requiring IMV.
Methods
We compared clinical outcomes between those receiving propofol compared to etomidate for induction among adults with AMI between October 2015 and December 2019 using the Vizient® Clinical Data Base, a multicenter, US national database. We used inverse probability treatment weighting (IPTW) to assess for the association between induction agent and in-hospital mortality.
Results
We identified 5,147 patients, 1,386 (26.9%) of received propofol and 3,761 (73.1%) received etomidate for IMV induction. The mean (SD) age was 66.1 (12.4) years, 33.0% were women, and 51.6% and 39.8% presented with STEMI and cardiogenic shock, respectively. Patients in the propofol group were more likely to require pre-intubation vasoactive medication and mechanical circulatory support (both, P<0.05). Utilization of propofol was associated with lower mortality compared to etomidate (32.3 vs. 36.1%, P=0.01). After propensity weighting, propofol use remained associated with lower mortality (weighted mean difference -4.7%; 95% Confidence interval: -7.6% to -1.8%, P=0.002). Total cost, ventilator days, and length of stay were higher in the propofol group (all, P<0.001).
Conclusions
Induction with propofol, compared with etomidate, was associated with lower mortality for patients with AMI requiring IMV. Randomized trials are needed to determine the optimal induction agent for this critically ill patient population.
更多查看译文
关键词
Acute myocardial infarction,Cardiogenic shock,Invasive mechanical ventilation,Rapid sequence intubation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要